The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
Northwestern Medicine scientists have demonstrated a new method that helps to pinpoint which genetic variants might be most important in the development of schizophrenia and related disorders.
A new study published in Nature Communications finds that practicing generosity activates an area of the brain associated with reward and happiness.
Kritika Nayar, a fourth-year student in the Clinical Psychology PhD Program, studies visual perception and its role in autism spectrum disorder in the laboratory of Molly Losh, PhD, associate professor of Psychiatry and Behavioral Sciences.
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
Dane Chetkovich, MD, PhD, professor of Neurology and director of the Medical Scientist Training Program, will be chair of Neurology at Vanderbilt University Medical Center.
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Northwestern Medicine scientists have developed a novel testing platform to assess, in real time, the efficacy of nanomaterials in regulating gene expression.
According to a new study, normal agers lost volume in the cortex, which contains neurons, twice as fast as SuperAgers, a rare group of older people whose memories are as sharp as those decades younger.